Alzheimer's disease treatment: Assessing caregiver preferences for mode of treatment delivery

Advances in Therapy

Volumn 26, Issue 6, 2009, Pages 627-644

  Abetz, Linda ^a   Rofail, Diana ^a   Mertzanis, Polyxane ^a   Heelis, Rebecca ^a   Rosa, Kathleen ^a   Tellefsen, Crystal ^a   Roborel De Climens, Aude ^a   McBurney, Christopher ^b   Thomas, Simu ^b  

^a MAPI VALUES   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Alzheimer's disease; Caregiver questionnaire; Oral capsule; Rivastigmine; Transdermal patch; Treatment preference; Treatment satisfaction

Indexed keywords

ADULT; ALZHEIMER DISEASE; ALZHEIMER DISEASE CAREGIVER PREFERENCE QUESTIONNAIRE; ARTICLE; CAREGIVER; CAREGIVER SATISFACTION; CLINICAL PRACTICE; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERNAL CONSISTENCY; INTERVIEW; MALE; PATIENT COMPLIANCE; QUESTIONNAIRE; RELIABILITY; SATISFACTION; TREATMENT INDICATION; VALIDITY; AGED; ATTITUDE; INTRADERMAL DRUG ADMINISTRATION; MICROCAPSULE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATTITUDE; CAPSULES; CAREGIVERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT PREFERENCE; PSYCHOMETRICS; QUESTIONNAIRES; YOUNG ADULT;

EID: 73349130821     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0034-5     Document Type: Article

References (42)

1. S.H. Croog J.A. Burleson A. Sudilovsky R.M. Baume 2006 Spouse caregivers of Alzheimer patients: problem responses to caregiver burden Aging Ment Health 10 87 100 10.1080/13607860500492498 1:STN:280:DC%2BD287ivVSltw%3D%3D 16517483 (Pubitemid 43355118)
2. C. Donaldson N. Tarrier A. Burns 1998 Determinants of carer stress in Alzheimer's disease Int J Geriatr Psychiatry 13 248 256 10.1002/(SICI)1099- 1166(199804)13:4<248::AID-GPS770>3.0.CO;2-0 1:STN:280:DyaK1czhtVWhsw%3D%3D 9646153 (Pubitemid 28192679)
3. H. Takechi H. Yamada Y. Sugihara T. Kita 2006 Behavioral and psychological symptoms, cognitive impairment and caregiver burden related to Alzheimer's disease patients treated in an outpatient memory clinic [in Japanese] Nippon Ronen Igakkai Zasshi 43 207 216 16683655
4. K.M. Sink K.E. Covinsky D.E. Barnes 2006 Caregiver characteristics are associated with neuropsychiatric symptoms of dementia J Am Geriatr Soc 54 796 803 10.1111/j.1532-5415.2006.00697.x 16696746 (Pubitemid 44030202)
5. R. Mahoney C. Regan C. Katona 2005 Anxiety and depression in family caregivers of people with Alzheimer disease: the LASER-AD study Am J Geriatr Psychiatry 13 795 801 16166409
6. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims [draft guidance]. FDA web site. February 2006. Available at: www.fda.gov/cder/guidance/5460dft.pdf. Accessed June 2006.
7. Boyd MA. Psychiatric Nursing: Contemporary Practice. 3rd edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
8. Travis SS, Kao HF, Acton GJ. Helping family members manage medication administration hassles. J Psychiatr Ment Health Nurs. 2005;2005:13-15.
9. P.W. Slattum M.A. Johnson 2004 Caregiver burden in Alzheimer's disease Consult Pharm 19 352 362 16553479
10. C. Valle-Jones J. O'Hara H. O'Hara 1989 Comparative clinical trial of the tolerability, patient acceptability and efficacy of two transdermal glyceryl trinitrate patches ('Deponit' 5 and 'Transiderm-Nitro' 5) in patients with angina pectoris Curr Med Res Opin 11 331 339 1:STN:280:DyaL1M7ps1Snsw%3D%3D 2495215
11. L. Allan H. Hays N.H. Jensen 2001 Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain BMJ 322 1154 1158 10.1136/bmj.322.7295.1154 1:CAS:528: DC%2BD3MXktlequ7Y%3D 11348910
12. V.L. Baker 1994 Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery Obstet Gynecol Clin North Am 21 271 297 1:STN:280: DyaK2M%2Fit1GhsQ%3D%3D 7936545
13. G.C. Branche Jr. J.M. Batts V.M. Dowdy L.S. Field C.K. Francis 1991 Improving compliance in an innercity hypertensive patient population Am J Med 91 37S 41S 10.1016/0002-9343(91)90061-2 1867227
14. J.F. Burris V. Papademetriou J.D. Wallin M.E. Cook D.J. Weidler 1991 Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension Am J Med 91 22S 28S 10.1016/0002-9343(91)90059-7 1:STN:280:DyaK3MzivVWrsA%3D%3D 1867225
15. J.F. Burris 1993 The USA experience with the clonidine transdermal therapeutic system Clin Auton Res 3 391 396 10.1007/BF01829459 1:STN:280:DyaK2c3ltFWjsw%3D%3D 8193527
16. B. Donner M. Zenz 1995 Transdermal fentanyl: a new step on the therapeutic ladder Anticancer Drugs 6 suppl.3 39 43 10.1097/00001813-199504003- 00007 1:CAS:528:DyaK28Xis12gu7c%3D 7606035
17. T. Jeck D. Edmonds T. Mengden 1992 Betablocking drugs in essential hypertension: transdermal bupranolol compared with oral metoprolol Int J Clin Pharmacol Res 12 139 148 1:STN:280:DyaK3s7hsV2htQ%3D%3D 1473881
18. S. Parker M. Armitage 1999 Experience with transdermal testosterone replacement therapy for hypogonadal men Clin Endocrinol (Oxf) 50 57 62 10.1046/j.1365-2265.1999.00596.x 1:CAS:528:DyaK1MXhslSju7o%3D (Pubitemid 29079368)
19. R. Payne S.D. Mathias D.J. Pasta L.A. Wanke R. Williams R. Mahmoud 1998 Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine J Clin Oncol 16 1588 1593 1:CAS:528: DyaK1cXis1Ghtrg%3D 9552070
20. M. Martens 1997 Efficacy and tolerability of a topical NSAID patch (local action transcutaneous flurbiprofen) and oral diclofenac in the treatment of softtissue rheumatism Clin Rheumatol 16 25 31 10.1007/BF02238759 1:STN:280:DyaK2s3gsFynsw%3D%3D 9132322 (Pubitemid 27101288)
21. W.H. Utian 1987 Transdermal estradiol overall safety profile Am J Obstet Gynecol 156 1335 1338 1:STN:280:DyaL2s3htVClsg%3D%3D 2953248
22. J.O. Wong G.L. Chiu C.J. Tsao C.L. Chang 1997 Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain Acta Anaesthesiol Sin 35 25 32 1:STN:280:DyaK2szlsF2qtQ%3D%3D 9212478
23. Y. Lake S. Pinnock 2000 Improved patient acceptability with a transdermal drug-in-adhesive oestradiol patch Aust N Z J Obstet Gynaecol 40 313 316 10.1111/j.1479-828X.2000.tb03341.x 1:STN:280:DC%2BD3crhtVGqtw%3D%3D 11065040
24. S. Riley B. Morris L. Walker P. Reese L. White 1992 Comparison of two transdermal nitroglycerin systems: Transderm-Nitro and Nitro-Dur Clin Ther 14 438 445 1:STN:280:DyaK38zks1Klsw%3D%3D 1638585
25. L. Radbruch R. Sabatowski F. Elsner G. Loick N. Kohnen 2002 Patients' associations with regard to analgesic drugs and their forms for application - a pilot study Support Care Cancer 10 480 485 10.1007/s00520-002-0361-4 12353127 (Pubitemid 36056273)
26. E. Gomez-Panzani M.B. Williams J.T. Kuznicki 2000 Application and maintenance habits do make a difference in adhesion of Alora transdermal systems Maturitas 35 57 64 10.1016/S0378-5122(00)00100-6 1:CAS:528:DC%2BD3cXjtVCjs70%3D 10802401 (Pubitemid 30236282)
27. C. Reddington J. Cohen A. Baldillo 2000 Adherence to medication regimens among children with human immunodeficiency virus infection Pediatr Infect Dis J 19 1148 1153 10.1097/00006454-200012000-00005 1:STN:280:DC%2BD3MzitV2nuw%3D%3D 11144374 (Pubitemid 32003357)
28. B. Donner M. Zenz M. Tryba M. Strumpf 1996 Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain Pain 64 527 534 10.1016/0304-3959(95)00180-8 1:CAS:528:DyaK28Xkt1ektbo%3D 8783318 (Pubitemid 26180159)
29. S. Ahmedzai 1997 New approaches to pain control in patients with cancer Eur J Cancer 33 suppl.6 S8 S14 10.1016/S0959-8049(97)00205-0 1:CAS:528:DyaK2sXlvVaksLg%3D 9404234
30. S. Ahmedzai D. Brooks 1997 Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group J Pain Symptom Manage 13 254 261 10.1016/S0885-3924(97)00082-1 1:STN:280:DyaK2szivV2nsg%3D%3D 9185430 (Pubitemid 27240678)
31. P. Lopes S. Rozenberg J. Graaf E. Fernandez-Villoria L. Marianowski 2001 Aerodiol versus the transdermal route: perspectives for patient preference Maturitas 38 suppl.1 S31 S39 10.1016/S0378-5122(01)00202-X 1:CAS:528: DC%2BD3MXotVWru7c%3D 11390122
32. L. Hollister N. Gruber 1996 Drug treatment of Alzheimer's disease. Effects on caregiver burden and patient quality of life Drugs Aging 8 47 55 10.2165/00002512-199608010-00008 1:CAS:528:DyaK28XmsFGgtL8%3D 8785468
33. K. Howard K. Rockwood 1995 Quality of life in Alzheimer's disease Dementia 6 113 116 1:STN:280:DyaK2MzjtVWjsA%3D%3D 7606279
34. R.G. Steele B. Anderson B. Rindel 2001 Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs AIDS Care 13 617 629 10.1080/09540120120063241 1:STN:280: DC%2BD3Mritl2mtw%3D%3D 11571008 (Pubitemid 32928069)
35. B. Winblad A.K. Kawata K.M. Beusterien 2007 Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease Int J Geriatr Psychiatry 22 485 491 10.1002/gps.1806 17407176 (Pubitemid 46831693)
36. B. Winblad J. Cummings N. Andreasen 2007 A 6-month, double-blind, randomized, placebo-controlled study of a transxdermal patch in Alzheimer's disease - rivastigmine patch versus capsule Int J Geriatr Psychiatry 22 456 467 10.1002/gps.1788 17380489 (Pubitemid 46831690)
37. Glaser BG, Strauss A. The Discovery of Grounded Theory: Strategies for Qualitative Research. Mill Valley, CA: Sociology Press; 1967.
38. R.L. Oliver 1980 A cognitive model of the antecedents and consequences of satisfaction decisions J Marketing Res 17 460 469 10.2307/3150499
39. R. Hays T. Hayashi 1990 Beyond internal consistency reliability: rationale and user's guide for Multitrait Analysis Program on the microcomputer Behav Res Methods 22 167 175
40. L.J. Cronbach 1951 Coefficient alpha and the internal structure of tests Psychometrika 16 297 334 10.1007/BF02310555
41. Nunnally JC, Bernstein IH. Chapter 7: The assessment of reliability. In: Psychometric Theory. 3rd edition. New York: McGraw-Hill, Inc.; 1994: 248-292.
42. A.M. Epstein J.A. Hall J. Tognetti L.H. Son L.J. Conant 1989 Using proxies to evaluate quality of life. Can they provide valid information about patients' health status and satisfaction with medical care? Med Care 27 S91 S98 10.1097/00005650-198903001-00008 1:STN:280:DyaL1M7lvVegsQ%3D%3D 2921889